Cargando…

Primary care providers should prescribe aspirin to prevent cardiovascular disease based on benefit−risk ratio, not age

Recent guidelines restricted aspirin (ASA) in primary prevention of cardiovascular disease (CVD) to patients <70 years old and more recent guidance to <60. In the most comprehensive prior meta-analysis, the Antithrombotic Trialists Collaboration reported a significant 12% reduction in CVD with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Kyungmann, Hennekens, Charles H, Martinez, Lisa, Gaziano, J Michael, Pfeffer, Marc A, Biglione, Bianca, Gitin, Alexander, McCabe, Jeanne Bell, Cook, Thomas D, DeMets, David L, Wood, Sarah K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710906/ https://www.ncbi.nlm.nih.gov/pubmed/34952844 http://dx.doi.org/10.1136/fmch-2021-001475

Ejemplares similares

Dose of aspirin to prevent preterm preeclampsia in women with moderate or high-risk factors: A systematic review and meta-analysis
por: Van Doorn, Rachel, et al.
Publicado: (2021)

Prescribing Aspirin for Preeclampsia Prevention in Pregnant Women During COVID-19: Should or Shouldn’t?
por: Eslamian, Laleh, et al.
Publicado: (2021)

Data monitoring committees: history and their future
por: DeMets, David L
Publicado: (2013)

Updates on Hydroxychloroquine in Prevention and Treatment of COVID-19
por: Hennekens, Charles H., et al.
Publicado: (2022)

Updates for Health Providers on Monoclonal Antibodies for COVID-19: Less Promising Adjunct and Never an Alternative to Vaccinations
por: Berges, Maja, et al.
Publicado: (2022)

Genomic surveillance to combat COVID-19: challenges and opportunities
por: Robishaw, Janet D, et al.
Publicado: (2021)

Point of care testing for improving risk- benefit ratio of aspirin and warfarin
por: Sheth, Harsh, et al.
Publicado: (2014)

Data monitoring in clinical trials: a case studies approach
por: DeMets, David, et al.
Publicado: (2006)

Achieving effective informed oversight by DMCs in COVID clinical trials
por: DeMets, David L., et al.
Publicado: (2020)

Missed opportunities in aspirin prescribing for preeclampsia prevention
por: Singh, Noreen, et al.
Publicado: (2023)

If you thought you were good with a scalpel, you should try this
por: McCabe, Kate, et al.
Publicado: (2011)

Type 2 diabetes mellitus development programs in the new regulatory environment with cardiovascular safety requirements
por: Yang, Fred, et al.
Publicado: (2015)

Monitoring clinical trials in infectious diseases
por: DeMets, David L, et al.
Publicado: (2021)

Critical Overview on the Benefits and Harms of Aspirin
por: Kwok, Chun Shing, et al.
Publicado: (2010)

Fundamentals of Clinical Trials
por: Friedman, Lawrence M, et al.
Publicado: (2010)

Statins: the high risks of discontinuation and large benefits of continuation
por: Hennekens, Charle H., et al.
Publicado: (2011)

Evolution of Knowledge in the Treatment of Long-Standing Atrial Fibrillation in a UK Tennis Champion
por: Krishnaswamy, Shiv, et al.
Publicado: (2021)

Estimates of benefits and harms of prophylactic use of aspirin in the general population
por: Cuzick, J., et al.
Publicado: (2015)

Ivermectin in COVID-19: The Case for a Moratorium on Prescriptions
por: Molnar, Andreea, et al.
Publicado: (2022)

Should Physicians Prescribe Alcoholic Stimulants
por: McCormick, A. Y.
Publicado: (1871)

Should aspirin be used for prophylaxis of COVID-19-induced coagulopathy?
por: Mohamed-Hussein, Aliae A.R., et al.
Publicado: (2020)

Bleeding Risk with Long-Term Low-Dose Aspirin: A Systematic Review of Observational Studies
por: García Rodríguez, Luis A., et al.
Publicado: (2016)

Impact of recent guideline changes on aspirin prescribing after knee arthroplasty
por: Shah, Sarav S., et al.
Publicado: (2016)

Assessment of an Intervention to Reduce Aspirin Prescribing for Patients Receiving Warfarin for Anticoagulation
por: Schaefer, Jordan K., et al.
Publicado: (2022)

Aspirin: 120 years of innovation. A report from the 2017 Scientific Conference of the International Aspirin Foundation, 14 September 2017, Charité, Berlin
por: Walker, Jaqui, et al.
Publicado: (2018)

Prescribing gliptins: Enthusiasm should be coupled with caution
por: Garg, M. K., et al.
Publicado: (2012)

Which people should take aspirin for primary prevention of cardiovascular disease?
por: Lozano, Roberto, et al.
Publicado: (2015)

Should Aspirin Be Used for the Primary Prevention of Cardiovascular Disease in the General Population?
por: Huang, Qing-Yu, et al.
Publicado: (2015)

Should aspirin be replaced with ADP blockers and anti-GPVI to manage thrombosis?
por: Khan, Hafsa, et al.
Publicado: (2022)

Aspirin has potential benefits for primary prevention of cardiovascular outcomes in diabetes: updated literature-based and individual participant data meta-analyses of randomized controlled trials
por: Seidu, Samuel, et al.
Publicado: (2019)

Should I take aspirin? A qualitative study on the implementation of a decision aid on taking aspirin for bowel cancer prevention
por: Onwuka, Shakira, et al.
Publicado: (2023)

Are null segregants new combinations of heritable material and should they be regulated?
por: Heinemann, Jack A., et al.
Publicado: (2023)

Should We Prescribe Calcium Supplements For Osteoporosis Prevention?
por: Reid, Ian R
Publicado: (2014)

Should Medical Practitioners Dispense?: III. Prescriber and Dispenser
Publicado: (1910)

Should we prescribe montelukast to allergic pediatric patients?
por: Park, Yong Mean
Publicado: (2020)

Evidence should inform more than prescribing decisions
por: Cowdell, Fiona
Publicado: (2022)

Proton-pump inhibitors should be strictly prescribed in clinic
por: Yang, Xuesong, et al.
Publicado: (2022)

Should gastroenterologists prescribe cannabis? The highs, the lows and the unknowns
por: Samuel, Sonia, et al.
Publicado: (2023)

An activist's argument that participant values should guide risk–benefit ratio calculations in HIV cure research
por: Evans, David
Publicado: (2017)

ASPIRIN BENEFIT IS NOT AFFECTED BY BODY WEIGHT IN HEALTHY OLDER PERSONS
por: Woods, Robyn L, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_uup8f705781qmjne5ed7fhi6r5